Karen Rascati, Ph.D.

Karen Rascati Profile Pic

Professor of Health Outcomes
Stewart Turley/Eckerd Corporation Centennial Endowed Professor
Graduate Advisor

Karen L. Rascati, RPh, PhD, is the Eckerd/Turley Centennial Endowed Professor of Health Outcomes at The University of Texas (UT) College of Pharmacy and the Graduate Advisor for the College. She received her Pharmacy degree from the University of Florida and worked as a pharmacist in both community and hospital settings. She returned to the University of Florida and received her PhD degree in Health Outcomes & Pharmacy Practice, with a concentration in health care policy and economics.

Upon graduation, she joined the University of Texas, where she serves as Graduate Advisor for the 100+ graduate students at the College, as well as faculty advisor to both the UT chapter of the Rho Chi National Pharmacy Honor Society and advisor to the first student International Society of Pharmacoeconomics and Outcomes Research (ISPOR) chapter and co-advisor of the Pharmacy Graduate Student Association (PGSA). She has supervised 70 MS and PhD students.  She received a University of Texas Excellent Teaching Award (TETA) and was awarded the 2010 Outstanding Alumnus Award by the University of Florida College of Pharmacy.

Dr. Rascati has been elected to numerous offices within the American Pharmacists Association (APhA) Science Section and was recognized as a 1999 APhA Fellow (FAPhA).  She has also served on various committees within the American Association of Colleges of Pharmacy (AACP). Dr. Rascati was elected to a 6-year term with the National Rho Chi Honor Society (President-elect 2006-2008, President 2008-2010, Past-president 2010-2012).  She is a charter member of ISPOR – founded in 1995 – where she has contributed in many capacities, including serving as Chair of the Education Committee and on the Vision 2010 and Vision 2020 Task Force Committees. She served as a member of the ISPOR Board of Directors (1999-2001) in addition to two three-year terms as Treasurer (2007-2010; 2010-2013).  In 2014, Dr. Rascati received the first ISPOR Marilyn Dix Smith Leadership Award – named after the retiring founding Executive Director of the Organization.  She is currently an Assistant Editor for the Journal of Managed Care & Specialty Pharmacy (JMCP).

She has authored or co-authored more than 150 publications (including five textbook chapters) and more than 200 national and international presentations.  Dr. Rascati is author of “Essentials of Pharmacoeconomics,” which is the most commonly used textbook on the topic in US Colleges of Pharmacy.  The first edition of the book won the University of Texas Hamilton Book Award in 2009 and has been translated into Portuguese. The third edition became available in 2020, and a link to information about this book is available under the Books/Book Chapters tab.

Dr. Rascati’s research interests include economic and outcomes evaluations for several disease states as well as for pharmacy services.  She has conducted over 60 funded research projects and has served on various grant review panels.

Dr. Rascati's body of work includes numerous publications and presentations in the following five core research areas.  Please see below for additional information and selected publications and presentations.

  • Healthcare Utilization and Costs
  • Health Outcomes and Value Assessment
  • Medication Use and Adherence
  • Health Behavior / Health Disparities
  • Integrative Clinical Practice, Pharmacy Practice, and Education
     

HEALTHCARE UTILIZATION AND COSTS

2021     Wong B, Deng Y, Rascati KL. Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring (rtCGM) versus Traditional Blood Glucose Monitoring (BG) among US Adults with Type 1 Diabetes. Journal of Diabetes Science and Technology. (August 2021).

2021     Liang Y; Rascati K; Richards K. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries. Current medical research and opinion (2021 Aug) Vol. 37:8, 1315-1322.

2021     Zhang S; Rascati KL.  Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention. Current medical research and opinion. (2021 Jun) 1-9.

2021     Shao Q; Rascati KL; Lawson KA; Wilson JP; Shah S; Garrett JS.  Impact of emergency department opioid use on future health resource utilization among patients with migraine. Headache (2021 Feb); 61(2): 287-299.

2021     Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K. Barriers to implementing pharmacoeconomics: interview study. Expert review of pharmacoeconomics & outcomes research (2021 Feb); 21(1): 93-104.

2020     Rascati KL. Economic evaluations of clinical pharmacy services: What's next? J Am Coll Clin Pharm, Vol 3 (4) June 2020; 716.

2018      Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode.” Drugs in R&D.  2017;17(3):487-488.

2018       Popp R, Rascati K, Davis M, Patel U. Refining a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Cost per Effectively Treated Patient with Rheumatoid Arthritis. Pharmacotherapy. February 2018;38(2):172-180.

2017       Alefan Q, Rascati K. Pharmacoeconomic Studies in World Health Organization Eastern Mediterranean Countries: Reporting Completeness. International Journal of Technology Assessment in Health Care June 5, 2017;1-7.

2017       Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”. Drugs in R&D, May 20, 2017

2017       Heo J, Rascati K, Lee E. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value in Health Regional Issues. May 2017;12:7-19.

2017       Ling Y, Rascati K, Pawaskar M. Direct and indirect costs among patients with binge-eating disorder in the United States. International Journal of Eating Disorders. May 2017;50(5):523-532.

2015       Park, H., Adeyemi, A. O., & Rascati, K. L. (2015). Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007-2011 Medical Expenditure Panel Survey. Clinical Therapeutics, 1466-1476. doi:10.1016/j.clinthera.2015.04.013

2015       Park, H., Rascati, K. L., & Keith, M. S. (2015). Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations. Journal Of Managed Care & Specialty Pharmacy, 21(6), 507-514.

2015       Park, H., Rascati, K. L., Lawson, K. A., Barner, J. C., Richards, K. M., & Malone, D. C. (2015). Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis. Journal Of Managed Care & Specialty Pharmacy, 21(10), 956-964.

2014       Scalo, J. F., & Rascati, K. L. (2014). Trends and issues in oncology costs. Expert Review Of Pharmacoeconomics & Outcomes Research, 14(1), 35-44. doi:10.1586/14737167.2014.864561

2013       Chandwani, H. S., Strassels, S. A., Rascati, K. L., Lawson, K. A., & Wilson, J. P. (2013). Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events. Journal Of Pain & Palliative Care Pharmacotherapy, 27(3), 206-213. doi:10.3109/15360288.2013.803511

2012       Cheng, L., & Rascati, K. L. (2012). Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Arthritis Care & Research, 64(9), 1423-1429. doi:10.1002/acr.21696

2012       Park, H., Rascati, K. L., Prasla, K., & McBayne, T. (2012). Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout. Clinical Therapeutics, 34(3), 640-652. doi:10.1016/j.clinthera.2012.01.020

2012       Tiwana, S. K., Rascati, K. L., & Park, H. (2012). Cost-effectiveness of expanded newborn screening in Texas. Value In Health: The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 15(5), 613-621. doi:10.1016/j.jval.2012.02.007

2011       Kim, Y. A., Loucks, A., Yokoyama, G., Lightwood, J., Rascati, K., & Serxner, S. A. (2011). Evaluation of Value-Based Insurance Design With a Large Retail Employer. American Journal Of Managed Care, 17(10), 682-690.

2011       Park, H., Rascati, K. L., Keith, M. S., Hodgkins, P., Smyth, M., Goldsmith, D., & Akehurst, R. (2011). Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value In Health: The Journal Of The International Society For Pharmacoeconomics And Outcomes Research, 14(8), 1002-1009. doi:10.1016/j.jval.2011.05.043

2011       Rascati, K., Richards, K., Ott, C., Goddard, A., Stafkey-Mailey, D., Alvir, J., & … Mychaskiw, M. (2011). Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatric Services, 62(9), 1032-1040.

2010       Barnes, J. N., & Rascati, K. L. (2010). Switching of antiepileptic drug formulations. The Journal Of Pediatric Pharmacology And Therapeutics: JPPT: The Official Journal Of PPAG, 15(2), 64-65.

2009       Park, H., & Rascati, K. L. (2009, December). Comparing two cost-effectiveness studies of statins for the primary prevention of cardiovascular disease: Are statins cost-effective from a Korean health system perspective?. Clinical Therapeutics. pp. 2916-2918. doi:10.1016/j.clinthera.2009.12.009.

2008       Yarger, S., Rascati, K., Lawson, K., Barner, J., & Leslie, R. (2008). Analysis of predictive value of four risk models in medicaid recipients with chronic obstructive pulmonary disease in Texas. Clinical Therapeutics, 301051-1057. doi:10.1016/j.clinthera.2008.06.001

2007       Rascati, K. L., Akazawa, M., Johnsrud, M., Stanford, R. H., & Blanchette, C. M. (2007). Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clinical Therapeutics, 29(6), 1203-1213.

2006       Patel, N., Crismon, M., Hoagwood, K., Johnsrud, M., Rascati, K., & Wilson, J. (2006). Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Medical Care, 44(1), 87-90.

2005       Rascati, K. L., Stanford, R. H., & Borker, R. (2005). A comparison of the risk of hospitalizations due to chronicobstructive pulmonary disease in medicaid patients with various medication regimens, including ipratropium, inhaled corticosteroids, salmeterol, or their combination. Clinical Therapeutics, 27(3), 346-354.

2005       Smith, M. J., Rascati, K. L., & Barner, J. C. (2005). A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program. The Journal Of Asthma: Official Journal Of The Association For The Care Of Asthma, 42(6), 447-453.

2005       Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., & Jensen, P. S. (2005). Trends in the Use of Typical and Atypical Antipsychotics in Children and Adolescents. Journal Of The American Academy Of Child & Adolescent Psychiatry, 44(6), 548-556. doi:10.1097/01.chi.0000157543.74509.c8

2003       Rascati, K., Johnsrud, M., Crismon, M., Lage, M., & Barber, B. (2003). Olanzapine versus risperidone in the treatment of schizophrenia – A comparison of costs among texas medicaid recipients. Pharmacoeconomics (New Zealand), 21(Oct), 683-697.

2002       Balkrishnan, R., Camacho, F. T., Smith, B. P., Shilt, J. S., Jacks, L. K., Koman, L. A., & … Mooney, J. 3. (2002). Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. Journal Of The Southern Orthopaedic Association, 11(2), 71-79.

2001       Rascati, K. L., Smith, M. J., & Neilands, T. (2001). Dealing with skewed data: an example using asthma-related costs of medicaid clients. Clinical Therapeutics, 23(3), 481-498.

2001       Rascati, K., Godley, P., & Pham, H. (2001). Evaluation of resources used to treat adverse events of selective serotonin reuptake inhibitor use. J. Manage. Care Pharm, 7(Sep-Oct), 402-406.

1999       Khan, Z. M., Rascati, K. L., & Koeller, J. M. (1999). Economic analysis of carboplatin versus cisplatin in lung and ovarian cancer. Pharmacoeconomics, 16(1), 43-57.

1999       Marsh, W. A., & Rascati, K. L. (1999). Meta-analyses of the effectiveness of erythropoietin for end-stage renal disease and cancer. Clinical Therapeutics, 21(9), 1443-1455.

1999       Okano, G. J., Rascati, K. L., Wilson, J. P., & Remund, D. D. (1999). A comparison of antihypertensive medication utilization before and after guideline changes using the Department of Defense Prescription Database. The Annals Of Pharmacotherapy, 33(5), 548-553.

1999       Rascati, K. L., & Gagnon, J. P. (1999). Report of a panel discussion: pharmacoeconomic education, managed care, and the pharmaceutical industry. American Journal Of Pharmaceutical Education (USA), 63(Apr), 449-453.

1997       Okano, G. J., Rascati, K. L., Wilson, J. P., Remund, D. D., Grabenstein, J. D., & Brixner, D. I. (1997). Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clinical Therapeutics, 19(6), 1433-1445.

1995       Burch, C. J., & Rascati, K. (1995). Promotion of the appropriate use of outpatient drug therapy in the Texas Medicaid Program through retrospective drug use review. Pharmacy Practice Management Quarterly, 15(2), 57-64.

1995       Rascati, K. (1995). Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications. Clinical Therapeutics: The International Peer-Reviewed Journal Of Drug Therapy, 17(4), 786-790. doi:10.1016/0149-2918(95)80055-7

1993       Rascati, K. L., & Rascati, E. J. (1993). Use of clozapine in Texas state mental health facilities. American Journal Of Hospital Pharmacy, 50(8), 1663-1666.

 

HEALTH OUTCOMES AND VALUE ASSESSMENT

2021     Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients. Clinical drug investigation. (2021 Mar). Vol 41:3); 245-253.

2021     Toliver JC; Barner JC; Lawson KA; Rascati KL. Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population. Multiple sclerosis and related disorders. (2021 Apr). Vol 49; 102741.

2021     Heo JH; Park C; Ghosh S; Park SK; Zivkovic M; Rascati KL. A network meta-analysis of efficacy and safety of first-line and second-line therapies for the management of metastatic renal cell carcinoma. Journal of clinical pharmacy and therapeutics. (2021 Feb). Vol 46:1. P. 35-49.

2020     Toliver JC; Barner JC; Lawson K; Sonawane K; Rascati K. Replication of a Claims-based Algorithm to Estimate Multiple Sclerosis Disease Severity in a Commercially Insured Population. Multiple sclerosis and related disorders (2020 Nov) Vol 46. 102539

2019       Pineda E, Goble J, Zolfaghari K, Godley PJ, Copeland L, Hartzel DN, Rascati K, Webster L. Prevalence of Primary Immune Thrombocytopenia Among Texas Medicaid Beneficiaries: Analyses of an Administrative Claims Database. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Liang Y, Rascati K. Prevalence of Primary Immune Thrombocytopenia Among Texas Medicaid Beneficiaries: Analyses of an Administrative Claims Database. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Kanu C, Brown C, Rascati K, Moczygemba L, Mackert M, Wilfong L. The Relationship between Health Literacy, Patient Activation, and Health Outcomes in Breast Cancer Patients. APhA Annual Meeting. Seattle, WA. March 2019.

2019        Kim N, Godley P, Rascati K, Michel J. Impact of Obesity on Real-World Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation on Direct Oral Anticoagulant Therapy: A Retrospective Cohort Study. AMCP Annual Meeting. San Diego, CA. March 25-28,2019.

2018       Grisham-Takac C, Lai P, Srinivasa M, Vasquez L, Rascati KL. Correlation of Antidepressant Target Dose Optimization and Achievement of Glycemic Control. The Mental Health Clinician (MHC)  CPNP Journal. 2018.

2018       Heo J, Rascati K, Lopez K, Moffett B. Increased Fracture Risk with Furosemide Use in Children with Congenital Heart Disease. The Journal of Pediatrics. May 9, 2018.

2018       Nduaguba S, Ford K, Rascati K. The Role of Physical Activity in the Association between Smoking Status and Quality of Life. Nicotine & Tobacco Research: Official Journal of The Society For Research On Nicotine And Tobacco. March 15, 2018.

2016       Tran M, Xiang P, Stanford R, et al. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission. Journal of Managed Care & Specialty Pharmacy. October 2016;22(10):1186-1193.

2015       Scalo, J., Desai, P., & Rascati, K. (2015). Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. Quality Of Life Research, 24(5), 1223-1233. doi:10.1007/s11136-014-0842-1

2014       Shcherbakova, N., Rascati, K., Brown, C., Lawson, K., Novak, S., Richards, K. M., & Yoder, L. (2014). Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. CNS Drugs, 28(11), 1047-1058. doi:10.1007/s40263-014-0191-1

2013       Rascati K, Richards K, Lopez D, Cheng L, & Wilson J. (2013). Progression to insulin for patients with diabetes mellitus on dual oral antidiabetic therapy using the US Department of Defense Database. Diabetes, Obesity & Metabolism, 15(10), 901-905. doi:10.1111/dom.12103

2012       Park, H., Park, C., Kim, Y., & Rascati, K. L. (2012). Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis. The Annals Of Pharmacotherapy, 46(11), 1453-1469. doi:10.1345/aph.1R041

2011       Rascati, K. L., Richards, K. M., Lopez, D., Cheng, L., & Wilson, J. P. (2011). Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database. Clinical Therapeutics, 33(12), 2016-2020. doi:10.1016/j.clinthera.2011.10.018

2009       Cheng, L., Oladapo, A., & Rascati, K. L. (2009). The need for validation studies of comorbidity adjustment instruments. Clinical Therapeutics, 31(7), 1578-1580. doi:10.1016/j.clinthera.2009.07.013

2009       Rascati, K. L., Richards, K. M., Johnsrud, M. T., & Mann, T. A. (2009). Effects of antiepileptic drug substitutions on epileptic events requiring acute care. Pharmacotherapy, 29(7), 769-774. doi:10.1592/phco.29.7.769

2006       Motsko, S., Rascati, K., Busti, A., Wilson, J., Worchel, J., & et, a. (2006). Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Safety (New Zealand), 29(Jul), 621-632.

2004       Smith, M. J., Rascati, K. L., & McWilliams, B. C. (2004). Inhaled anti-inflammatory pharmacotherapy and subsequent hospitalizations and emergency department visits among patients with asthma in the Texas Medicaid program. Annals Of Allergy, Asthma & Immunology: Official Publication Of The American College Of Allergy, Asthma, & Immunology, 92(1), 40-46.

2001       Rascati, K. L. (2001). Beyond efficacy: Consideration of humanistic outcomes. Drug Benefit Trends, 13(SupplD), 13-15.

 

MEDICATION USE AND ADHERENCE

2021     Burkhard A; Toliver J; Rascati K.  Association between multiple sclerosis disease severity and adherence to disease-modifying therapies.      Journal of managed care & specialty pharmacy. 2021 (Jul 27). Vol 7; 915-923.

2021     Makhinova T; Barner JC; Brown CM; Richards KM; Rascati KL; Rush S; Nag A. Examination of Barriers to Medication Adherence, Asthma Management, and Control Among Community Pharmacy Patients with Asthma. Journal of pharmacy practice (2021 Aug), Vol 34:4;  515-522.

2020     Zhang H, Barner JC, Moczygemba LR, Rascati KL. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes.   J Manag Care Spec Pharm, 2020 Nov;26(11):1434-1444.

2020     Shao Q, Rascati KL; Lawson KA; Wilson JP. Patterns and predictors of opioid use among migraine patients at emergency departments: A retrospective database analysis. Cephalalgia: an international journal of headache. (2020 Nov). Vol 40:13; 1489-1501.

2020     LaVallee C; Rascati KL; Gums TH. Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States. Journal of Clinical Hypertension. (2020 Nov) Vol  22:11: 2084-2092.

2019     Heo, J. H., Rascati, K. L., Wilson, J. P., Lawson, K. A., Richards, K. M., & Nair, R. (2019). Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension. Journal of Managed Care & Specialty Pharmacy, 25(9), 1001–1010.

2019       Pineda, E, Liao IC, Godley PJ, Michel J, Rascati K. Demographic and Clinical Profiles of Patients with Type 2 Diabetes Newly Initiating Sodium-Glucose Cotransporter-2 Inhibitors Compared to Glucagon-Like Peptide-1 Receptor Agonists. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Zhang S, Rascati K. Evaluation of Progesterone (17-Alpha Hydroxyprogesterone Caproate) Utilization and Adherence in Women With A High-Risk Pregnancy. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Shao Q, Rascati K, Shah S. Opioid Use Among Migraine Patients Presenting to the Emergency Department (ED) of a Large Tertiary Care Integrated Delivery Network in Texas. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Kang HA, Barner JC, Rascati K, Lawson KA, Mignacca R. Association Between Hydroxyurea Medication Adherence and All-Cause and Disease-Related Healthcare Expenditures Among Texas Medicaid Enrollees with Sickle Cell Disease. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2019        Brown G, Zhang S, Rascati K. Evaluation of Progesterone (17 α-Hydroxyprogesterone Caproate) Utilization and Adherence in Women with a High-risk Pregnancy Covered by Texas Medicaid. AMCP Annual Meeting. San Diego, CA. March 25-28,2019.

2019        Shao Q, Shah S, Rascati K. Opioid Use at the Emergency Department (ED) of a Large Tertiary Care Integrated Delivery Network in Texas. AMCP Annual Meeting. San Diego, CA. March 25-28,2019.

2018       Gupte-Singh K, Wilson JP, Barner JC, Richards KM, Rascati KL, Hovinga C. Patterns of Antiepileptic Drug Use in Patients with Potential Refractory Epilepsy in Texas MedicaidEpilepsy & Behavior. 2018 [online 16 August 2018]

2018       Makhinova T, Barner JC , Brown CM, Richards KM, Rascati KL, Barnes JN, Nag A. Adherence Enhancement for Patients with Asthma in Community Pharmacy Practice: Tools Development and Pharmacists’ FeedbackJournal for Pharmaceutical health Services Research. 2018 [online 03 July 2018]

2018       Nguyen T, Rascati KL, Temple H. Comparison of Medication Adherence Simulation in Professional Pharmacy Students versus Undergraduate Students. Currents in Pharmacy Teaching and Learning. January-February 2018;10(1):102-105.

2017       Rascati K, Worley K, Meah Y, Everhart D. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 Inhibitors. Journal of Managed Care & Specialty Pharmacy. March 2017;23(3):299-306.

2016       Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma. Journal of Managed Care & Specialty Pharmacy   Volume: 21  Issue: 12  Pages: 1124-1132  Published: DEC 2016

2016       Kim, Gilwan; Barner, Jamie C.; Rascati, Karen; et al. Examining Time to initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients with Rheumatoid Arthritis. Clinical Therapeutics   Volume: 38  Issue: 3  Pages: 646-654  Published: MAR 2016

2011       Kim YA, Rascati KL, Prasla K, Godley P, Goel N, Dunlop D. (2011). Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system. Clinical Therapeutics, 33(5), 598-607. doi:10.1016/j.clinthera.2011.04.021

2011       Rascati K, Richards K, Ott C, Goddard A, Stafkey-Mailey D, Alvir J, Mychaskiw M. (2011). Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatric Services, 62(9), 1032-1040.

2010       Adeyemi A, Rascati K, Strassels S. (2010). The need for oral antidiabetic treatment adherence studies in the pediatric population. Clinical Therapeutics, 32(7), 1306-1307. doi:10.1016/j.clinthera.2010.07.009

 

HEALTH BEHAVIOR / HEALTH DISPARITIES

2021     Kanu C; Brown CM; Rascati K; Moczygemba LR; Mackert M; Wilfong L. Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients? Health literacy research and practice (2021 Jul). Vol 5:3. e171-e178.

2020     Happe LE, Klepser D, McAdam-Marx C, McCart MS , Rascati KL, Rupp MT.  Racial disparities in medication use: JMCP’s response and call for submissions.  J Manag Care Spec Pharm, 2020 Nov;26(11):1475-1476.

2019     Nduaguba, S. O., Ford, K. H., & Rascati, K. The Role of Physical Activity in the Association Between Smoking Status and Quality of Life. Nicotine & Tobacco Research: Official Journal of The Society for Research on Nicotine And Tobacco, 21(8), 1065–1071, July 2019

2019       Orji C, Nduaguba S, Shukla N, Vohra Y, Rascati K. Health-Related Quality of Life Inequalities by Gender Identity And Sexual Orientation and Role Of Depression As An Explanatory Variable. ISPOR Annual Meeting. New Orleans, LA. May 2019.

2004       Opolka, J. L., Rascati, K. L., Brown, C. M., & Gibson, P. J. (2004). Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine. Psychiatric Services, 55(2), 151-156. doi:10.1176/appi.ps.55.2.151

2003       Opolka, J. L., Rascati, K. L., Brown, C. M., & Gibson, P. J. (2003). Role of ethnicity in predicting antipsychotic medication adherence. The Annals Of Pharmacotherapy, 37(5), 625-630.

2003       Opolka, J. L., Rascati, K. L., Brown, C. M., Barner, J. C., Johnsrud, M. T., & Gibson, P. J. (2003). Ethnic differences in use of antipsychotic medication among Texas Medicaid clients with schizophrenia. The Journal Of Clinical Psychiatry, 64(6), 635-639. doi:10.4088/JCP.v64n0603

 

INTEGRATIVE CLINICAL PRACTICE, PHARMACY PRACTICE, AND EDUCATION

EDUCATION

2018       Nguyen T, Rascati KL, Temple H. Comparison of Medication Adherence Simulation in Professional Pharmacy Students versus Undergraduate Students. Currents in Pharmacy Teaching and Learning. January-February 2018;10(1):102-105.

2017       Ogunsanya M,  Bamgbade B, Rascati KL. Determinants of Health-Related Quality Of Life in International Graduate StudentsCurrents in Pharmacy Teaching and Learning. 2018;10(4):413-422.

2017       Alefan Q, Rascati K. Pharmacoeconomic Studies in World Health Organization Eastern Mediterranean Countries: Reporting Completeness. International Journal of Technology Assessment in Health Care June 5, 2017;1-7.

2015       Alefan, Q. q., AlImam, S., Mukattash, T., Mhaidat, N., Alabbadi, I., & Rascati, K. (2015). Pharmacoeconomics education in WHO Eastern Mediterranean region. Currents In Pharmacy Teaching & Learning, 7(6), 819-825. doi:10.1016/j.cptl.2015.08.020

2013       Makhinova, T., & Rascati, K. (2013). Pharmacoeconomics Education in US Colleges and Schools of Pharmacy. American Journal Of Pharmaceutical Education, 77(7), 1-5.

2011       Kim, Y. A., Loucks, A., Yokoyama, G., Lightwood, J., Rascati, K., & Serxner, S. A. (2011). Evaluation of Value-Based Insurance Design With a Large Retail Employer. American Journal Of Managed Care, 17(10), 682-690.

2008       Millidhashni, R., Rascati, K., Wahawisan, J., & Rascati, M. (2008). Pharmacoeconomic Education in US Colleges and Schools of Pharmacy: An Update. American Journal Of Pharmaceutical Education, 72(3), 1-5.

2007       Nwokeji, E. D., Rascati, K. L., Moczygemba, L. R., & Wilson, J. P. (2007). Pharmacoepidemiology Education in US Colleges and Schools of Pharmacy. American Journal Of Pharmaceutical Education, 71(4), 1-5.

2005       Nwokeji, E. D., & Rascati, K. L. (2005). Pharmacoeconomic Education in Colleges of Pharmacy Outside of the United States. American Journal Of Pharmaceutical Education, 69(3), 348-355.

2004       Rascati, K. L., Drummond, M. F., Annemans, L., & Davey, P. G. (2004). Education in Pharmacoeconomics: An International Multidisciplinary View. Pharmacoeconomics, 22(3), 139-147.

PHARMACY PRACTICE

2021     Coleman A; Vohra Y; Rascati K; Kubes S; Moffett B. Antibiotic Utilization and Efficacy Associated with Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life. The Pediatric infectious disease journal (2021 Jul 27). 1532-0987.

2020     Pineda ED; Liao IC; Godley PJ; Michel JB; Rascati KL. Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications. Journal of managed care & specialty pharmacy (2020 May). Vol 26:5; 610 -618.

2019     Yu, S., Zolfaghari, K., Rascati, K. L., Copeland, L. A., Godley, P. J., & McNeal, C. Guidelines impact cholesterol management. Journal of Clinical Lipidology, 13(3), 432–442. May-June, 2019.

2017       Wong S, Barner J, Sucic K, Nguyen M, Rascati K. Integration of pharmacists into patient-centered medical homes in federally qualified health centers in Texas. Journal of The American Pharmacists Association: JAPhA. May 2017;57(3):375-381

2017       Rascati K, Worley K, Meah Y, Everhart D. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 inhibitors. Journal of Managed Care & Specialty Pharmacy. March 2017;23(3):299-306.

2016       Hinds, A., Lopez, D., Rascati, K., Jokerst, J., & Srinivasa, M. (2016). Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH. Diabetes Educator, 42(2), 228-233. doi:10.1177/0145721716631431

2016       Ko, J. J., Lu, J., Rascati, K., Stock, E. M., Juan, J., Suh, K., & … Godley, P. J. (2016). Analysis of Glycemic Control of a Pharmacist-Led Medication Management Program in Patients with Type 2 Diabetes. Journal Of Managed Care & Specialty Pharmacy, 22(1), 32-37. doi:10.18553/jmcp.2016.22.1.32

2016       Tran, M., Xiang, P., Rascati, K. L., Stock, E. M., Godley, P. J., Coleman, A., & … Stanford, R. H. (2016). Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission. Journal Of Managed Care & Specialty Pharmacy, 22(10), 1186-1193. doi:10.18553/jmcp.2016.22.10.1186

2014       Chung, N., Rascati, K., Lopez, D., Jokerst, J., & Garza, A. (2014). Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. Journal Of Managed Care & Specialty Pharmacy, 20(9), 914-919.

2012       Koranek, A., Smith, T., Mican, L., Rascati, K., Koranek, A. M., Smith, T. L., & … Rascati, K. L. (2012). Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility. Schizophrenia Research, 137(1-3), 137-140. doi:10.1016/j.schres.2012.01.043

2012       Oladapo, A. O., & Rascati, K. L. (2012). Review of Survey Articles Regarding Medication Therapy Management (MTM) Services/Programs in the United States. Journal Of Pharmacy Practice, 25(4), 457-470. doi:10.1177/0897190012442715

2007       Rascati, K. L., & Moczygemba, L. R. (2007). The need for pharmacoeconomic studies of pharmacy services. Clinical Therapeutics, 29(7), 1488-1490.

2007       Nwokeji, E., Rascati, K., Brown, C., & Eisenberg, A. (2007). Influences of attitudes on family physicians’ willingness to describe long-acting opioid analgesics for patients with chronic nonmalignant pain. Clinical Therapeutics, 29(Theme issue), 2589-2602.

1996       McArtor, J. P., & Rascati, K. L. (1996). Benefits of certification for pharmacy specialists. Journal Of The American Pharmaceutical Association (USA), NS36(Feb), 128-134.

1996       Rascati, K. L., Okano, G. J., & Burch, C. (1996). Evaluation of physician intervention letters. Medical Care, 34(8), 760-766.

1995       Borel, J. M., & Rascati, K. L. (1995). Effect of an automated, nursing unit-based drug-dispensing device on medication errors. American Journal Of Health-System Pharmacy: AJHP: Official Journal Of The American Society Of Health-System Pharmacists, 52(17), 1875-1879.

1994       Dobie, R. L., & Rascati, K. L. (1994). Documenting the value of pharmacist interventions. American Pharmacy (USA), NS34(May), 50-54.

1993       Malone, D. C., Rascati, K. L., & Gagnon, J. P. (1993). Consumers’ evaluation of value-added pharmacy services. American Pharmacy (USA), NS33(Mar), 48-56.

1993       Rao, V., & Rascati, K. L. (1993). Staff pharmacists’ opinions about performance appraisals. American Journal Of Hospital Pharmacy, 50(6), 1181-1185.

1993       Rascati, K. L., & Richards, J. (1993). Pharmacy students’ attitudes toward chemical dependency. Journal Of Pharmacy Teaching (USA), 4(Jan), 55-61.

1992       Rascati, K. L. (1992). Survey of formulary system policies and procedures. American Journal Of Hospital Pharmacy, 49(1), 100-103.

Publications

Selected Recent Publications (from over 150 publications)

Wong B, Deng Y, Rascati KL. Healthcare Utilization, Costs, and Adverse Events of Real-Time Continuous Glucose Monitoring (rtCGM) versus Traditional Blood Glucose Monitoring (BG) among US Adults with Type 1 Diabetes. Journal of Diabetes Science and Technology. (August 2021)

Liang Y; Rascati K; Richards K. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries. Current medical research and opinion (2021 Aug) Vol. 37:8, 1315-1322.

Makhinova T; Barner JC; Brown CM; Richards KM; Rascati KL; Rush S; Nag A. Examination of Barriers to Medication Adherence, Asthma Management, and Control Among Community Pharmacy Patients with Asthma. Journal of pharmacy practice (2021 Aug), Vol 34:4;  515-522.

Burkhard A; Toliver J; Rascati K.  Association between multiple sclerosis disease severity and adherence to disease-modifying therapies. Journal of managed care & specialty pharmacy. 2021 (Jul 27). Vol 7; 915-923.

Kanu C; Brown CM; Rascati K; Moczygemba LR; Mackert M; Wilfong L. Are Health Literacy and Patient Activation Related to Health Outcomes in Breast Cancer Patients? Health literacy research and practice (2021 Jul). Vol 5:3. e171-e178.

Coleman A; Vohra Y; Rascati K; Kubes S; Moffett B. Antibiotic Utilization and Efficacy Associated with Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients in the First Year of Life. The Pediatric infectious disease journal (2021 Jul 27). 1532-0987.                                  

Zhang S; Rascati KL.  Utilization, adherence, and outcomes of 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention. Current medical research and opinion. (2021 Jun) 1-9.                          

Pineda ED; Liao IC; Godley PJ; Michel JB; Rascati KL. Cardiovascular Outcomes Among Patients with Type 2 Diabetes Newly Initiated on Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Other Antidiabetic Medications. Journal of managed care & specialty pharmacy (2020 May). Vol 26:5; 610 -618.

Toliver JC; Barner JC; Lawson KA; Rascati KL. Use of a claims-based algorithm to estimate disease severity in the multiple sclerosis Medicare population. Multiple sclerosis and related disorders. (2021 Apr). Vol 49; 102741.

Ibiloye EA; Barner JC; Lawson KA; Rascati KL; Evoy KE; Peckham AM. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients. Clinical drug investigation. (2021 Mar). Vol 41:3); 245-253.

Shao Q; Rascati KL; Lawson KA; Wilson JP; Shah S; Garrett JS.  Impact of emergency department opioid use on future health resource utilization among patients with migraine. Headache (2021 Feb); 61(2): 287-299.

Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K. Barriers to implementing pharmacoeconomics: interview study. Expert review of pharmacoeconomics & outcomes research (2021 Feb); 21(1): 93-104

Heo JH; Park C; Ghosh S; Park SK; Zivkovic M; Rascati KL. A network meta-analysis of efficacy and safety of first-line and second-line therapies for the management of metastatic renal cell carcinoma. Journal of clinical pharmacy and therapeutics. (2021 Feb). Vol 46:1. P. 35-49

LaVallee C; Rascati KL; Gums TH Antihypertensive agent utilization patterns among patients with uncontrolled hypertension in the United States. Journal of clinical hypertension. (2020 Nov) Vol  22:11: 2084-2092.

Shao Q; Rascati KL; Lawson KA; Wilson JP. Patterns and predictors of opioid use among migraine patients at emergency departments: A retrospective database analysis. Cephalalgia : an international journal of headache. (2020 Nov). Vol 40:13; 1489-1501.

Toliver J; Barner JC; Lawson K; Sonawane K; Rascati K. Replication of a Claims-based Algorithm to Estimate Multiple Sclerosis Disease Severity in a Commercially Insured Population. Multiple sclerosis and related disorders (2020 Nov) Vol 46. 102539

Zhang H, Barner JC, Moczygemba LR, Rascati KL. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes. J Manag Care Spec Pharm, 2020 Nov;26(11):1434-1444.

Happe LE, Klepser D, McAdam-Marx C, McCart MS , Rascati KL ,Rupp MT.  Racial disparities in medication use: JMCP’s response and call for submissions. J Manag Care Spec Pharm, 2020 Nov;26(11):1475-1476.

Rascati KL. Economic evaluations of clinical pharmacy services: What's next? J Am Coll Clin Pharm, Vol 3 (4) June 2020; 716.

Heo, J. H., Rascati, K. L., Wilson, J. P., Lawson, K. A., Richards, K. M., & Nair, R. (2019). Comparison of Prostaglandin Analog Treatment Patterns in Glaucoma and Ocular Hypertension. Journal of Managed Care & Specialty Pharmacy, 25(9), 1001–1010.

Ghosh, S., Rascati, K. L., Shah, A., & Peeples, P. (2019). Predictors of Annual Base Salary for Health Economics, Outcomes Research, and Market Access Professionals in the Biopharmaceutical Industry. Journal of Managed Care & Specialty Pharmacy, 25(12), 1328–1333.

Nduaguba, S. O., Ford, K. H., & Rascati, K. The Role of Physical Activity in the Association Between Smoking Status and Quality of Life. Nicotine & Tobacco Research: Official Journal Of The Society For Research On Nicotine And Tobacco, 21(8), 1065–1071, July 2019

Yu, S., Zolfaghari, K., Rascati, K. L., Copeland, L. A., Godley, P. J., & McNeal, C. Guidelines impact cholesterol management. Journal of Clinical Lipidology, 13(3), 432–442. May-June, 2019.

Makhinova, T., Barner, J. C., Brown, C. M., Richards, K. M., Rascati, K. L., Rush, S., & Nag, A. Examination of Barriers to Medication Adherence, Asthma Management, and Control Among Community Pharmacy Patients with Asthma. Journal of Pharmacy Practice, April 2019.

Schwab, P., Racsa, P., Rascati, K., Mourer, M., Meah, Y., & Worley, K. A Retrospective Database Study Comparing Diabetes-Related Medication Adherence and Health Outcomes for Mail-Order Versus Community Pharmacy. Journal of Managed Care & Specialty Pharmacy, 25(3), 332–340, March 2019.

Conner, T., Cook, F., Fernandez, V., Rascati, K., & Rangel-Miller, V. An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States. Orphanet Journal of Rare Diseases, 14(1), 48, February, 2019.

Grisham-Takac C, Lai P, Srinivasa M, Vasquez L, Rascati KL.  Correlation of Antidepressant Target Dose Optimization and Achievement of Glycemic Control.  Mental Health Clinician (MHC)  CPNP Journal, Vol (9)1:12-17, January 2019.

Gupte-Singh K, Wilson JP, Barner JC, Richards KM, Rascati KL, Hovinga, C. Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid.  Epilepsy & Behavior: E&B. 87:108-116, October 2018.

Makhinova T, Barner JC, Brown CM, Richards KM, Rascati KL, J. Barnes N and Nag A.  Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback. Journal of Pharmaceutical Health Services Research. Vol 9 (3) September 2018.

Grisham-Takac C, Lai P, Srinivasa M, Vasquez L, Rascati KL. Correlation of Antidepressant Target Dose Optimization and Achievement of Glycemic Control. Accepted by The Mental Health Clinician (MHC) CPNP Journal, 2018.

Makhinova T, Barner JC , Brown CM, Richards KM, Rascati KL, Barnes N, Nag A. Adherence enhancement for patients with asthma in community pharmacy practice: tools development and pharmacists’ feedback. Accepted by Journal of Pharmaceutical Health Services Research.

Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”. Drugs in R&D. September 2017;17(3):487-488.

Ogunsanya M, Bamgbade B, Thach A, Sudhapalli P, Rascati K. Determinants of health-related quality of life in international graduate students. Currents in Pharmacy Teaching & Learning. April 2018;10(4):413-422.

Heo J, Rascati KL,  Moffett B, Lopez KN.  Association of Fractures with Furosemide Use in Pediatric Patients with Congenital Heart Disease. Pediatrics, accepted with revisions.

Ogunsanya M,  Bamgbade B, Rascati KL. Determinants of Health-Related Quality Of Life in International Graduate Students.   Currents in Pharmacy Teaching and Learning. accepted with revisions.

Popp R, Patel U, Davis M, Rascati KL. Using a Claims-based Algorithm to Estimate Biologic Medication Effectiveness and Medication Cost per Effectively-treated Patient in Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy –accepted with revisions.

Nguyen T, Rasati KL, Temple H.  Comparison of Medication Adherence Simulation in Professional Pharmacy Students versus Undergraduate Students. Currents in Pharmacy Teaching and Learning. In press.

Alefan Q, Rascati K. Pharmacoeconomic Studies in World Health Organization Eastern Mediterranean Countries: Reporting Completeness. International Journal of Technology Assessment in Health Care June 5, 2017;1-7.

Rascati K. Comment on: “Net Budgetary Impact of Ferric Citrate as a First-Line Phosphate Binder for the Treatment of Hyperphosphatemia: A Markov Microsimulation Mode”. Drugs in R&D, May 20, 2017

Heo J, Rascati K, Lee E. Prediction of Change in Prescription Ingredient Costs and Co-payment Rates under a Reference Pricing System in South Korea. Value in Health Regional Issues. May 2017;12:7-19.

Ling Y, Rascati K, Pawaskar M. Direct and indirect costs among patients with binge-eating disorder in the United States. International Journal of Eating Disorders. May 2017;50(5):523-532.

Rascati K, Worley K, Meah Y, Everhart D. Adherence, Persistence, and Health Care Costs for Patients Receiving Dipeptidyl Peptidase-4 inhibitors. Journal of Managed Care & Specialty Pharmacy. March 2017;23(3):299-306.

Tran M, Xiang P, Stanford R, et al. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission. Journal of Managed Care & Specialty Pharmacy. October 2016;22(10):1186-1193.

Hinds A, Lopez D, Rascati K, Jokerst J, Srinivasa M. Adherence to the 2013 Blood Cholesterol Guidelines in Patients With Diabetes at a PCMH: Comparison of Physician Only and Combination Physician/Pharmacist Visits. The Diabetes educator. 2016; 42(2):228-33.

Kim G, Barner JC, Rascati K, Richards K.  Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis. Clinical therapeutics. 2016; 38(3):646-54.

Park H; Rascati KL; Keith MS, Managing oral phosphate binder medication expenditures within the medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. Dialysis organizations. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2015 Jun; Vol. 21 (6), pp. 507-14

Park H; Adeyemi AO; Rascati KL. Direct Medical Costs and Utilization of Health Care Services to Treat Pneumonia in the United States: An Analysis of the 2007-2011 Medical Expenditure Panel Survey. Clinical Therapeutics [Clin Ther], ISSN: 1879-114X, 2015 May 19.

Kim G; Barner JC; Rascati K; Richards K. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas medicaid patients with rheumatoid arthritis. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2015 May; Vol. 21 (5), pp. 401-7.

Scalo J; Desai P; Rascati K,. Insomnia, hypnotic use, and health-related quality of life in a nationally representative sample. Quality Of Life Research: An International Journal Of Quality Of Life Aspects Of Treatment, Care And Rehabilitation [Qual Life Res], ISSN: 1573-2649, 2015 May; Vol. 24 (5), pp. 1223-33.

Shcherbakova N; Rascati K; Brown C; Lawson K; Novak S; Richards KM; Yoder L. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. CNS Drugs [CNS Drugs], ISSN: 1172-7047, 2014 Nov; Vol. 28 (11), pp. 1047-58.

Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2014 Jul; Vol. 20 (7), pp. 657-67.

Chung N; Rascati K; Lopez D; Jokerst J; Garza A. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2014 Sep; Vol. 20 (9), pp. 914-9.

Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC . Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. Journal of Managed Care & Specialty Pharmacy [J Manag Care Spec Pharm], ISSN: 2376-1032, 2014 Aug; Vol. 20 (8), pp. 862-76; Publisher: Academy of Managed Care Pharmacy.

Scalo JF; Rascati KL,. Trends and issues in oncology costs. Expert Review Of Pharmacoeconomics & Outcomes Research [Expert Rev Pharmacoecon Outcomes Res], ISSN: 1744-8379, 2014 Feb; Vol. 14 (1), pp. 35-44.

Makhinova T, Rascati KL. An update on pharmacoeconomic education for Doctor of Pharmacy students in US schools and colleges of pharmacy. Accepted by the American Journal of Pharmaceutical Education for 2013.

Oladapo A, Barner J, Rascati KL. The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services. Clinical Therapeutics; 2012: 34(11):2196-2199.

Park H, Park C, Kim YA, Rascati KL. Efficacy and safety of dipeptidyl peptidase-4 [DPP-4] inhibitors in type 2 diabetes: Meta-analysis. Annals Pharmacotherapy 2012: 46 (11), p 1453-1469.

Gavaza P, Rascati KL, Aladapo A, Khoza S. The State of Health Economic Research in South Africa. Pharmacoeconomics, 2012: 30 (10); 925-940.

Tiwana S, Rascati, KL, Park H. Cost-effectiveness of expanded newborn screening in Texas. Value In Health: The Journal of The International Society For Pharmacoeconomics And Outcomes Research, 2012: 15(5), 613-621.

Park H, Rascati K, Prasla K, McBayne T. Evaluation of health care costs and utilization patterns for patients with gout. Clinical Therapeutics, 2012: 34(3), 640-652.

Cheng L, Rascati K. Impact of Medicare part D for Medicare-age adults with arthritis: Prescription use, prescription expenditures, and medical spending from 2005 to 2008. Arthritis Care & Research, 2012: 64(9), 1423-1429

Khoza S, Barner, J, Bohman T, Rascati K, Lawson K, Wilson J. Use of antidepressants and the risk of type 2 diabetes mellitus: a nested case-control study. International Journal of Clinical Pharmacy, 2012: 34(3), 432-438.

Khoza S, Barner, J, Bohman T, Rascati K, Lawson K, Wilson J. Use of antidepressant agents and the risk of type 2 diabetes. European Journal of Clinical Pharmacology, 2012: 68(9), 1295-1302.

Koranek A, Smith T, Mican L, Rascati K. Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility. Schizophrenia Research, 2012: 137(1-3), 137-140.

Oladapo A, Barner, Rascati K, Strassels S. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid. Clinical Therapeutics, 2012: 34(3), 605-613.

Adeyemi A, Rascati K, Lawson K, Strassels S. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis. Clinical Therapeutics, 2012: 34(3), 712-719.

Dessi P, Chandwani H, Rascati, K. Assessing the quality of pharmacoeconomic studies in India: a systematic review. Pharmacoeconomics, 2012: 30(9), 749-762.

Park H, Rascati K, Keith M, Hodgkins P, Smyth M, Goldsmith D, Akehurst R. Cost-effectiveness of lanthanum carbonate versus sevelamer hydrochloride for the treatment of hyperphosphatemia in patients with end-stage renal disease: a US payer perspective. Value In Health: The Journal of The International Society For Pharmacoeconomics And Outcomes Research, 2011:14(8), 1002-1009.

Rascati KL, Richards K, Lopez D, Cheng L, Wilson J. Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database. Clinical Therapeutics, 2011: 33(12), 2016-2020.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, and Steinhardt M. Examination of Pharmacists’ Intention to Report Serious Adverse Drug Events (ADEs) to the FDA using the Theory of Planned Behavior. Research in Social and Administrative Pharmacy 2011: 7(4), 369-382.

Kim YA, Loucks A, Lightwood J, Yokokyama G, Rascati K, Serxner S. Evaluation of a value-based insurance design in a large retail employer: impact of adherence, utilization and costs. American Journal of Managed Care 2011;17 (10):682-690.

Rascati KL, Richards KM, Ott CA, Goddard AW et al. Adherence, Persistence of Use, and Costs Associated with Second-Generation Antipsychotics for Bipolar Disorder, Psychiatric Services , September 2011; Vol. 62, No. 9.

Kim Y, Rascati K, Prasla K, Godley P, Goel N, Dunlop D. Retrospective evaluation of the impact of copayment increases for specialty medications on adherence and persistence in an integrated health maintenance organization system. Clinical Therapeutics May 2011: 33(5):598-607

 

Books/Book Chapters

Click here for more information on Essentials of Pharmacoeconomics

  1. Rascati KL.  Essentials of Pharmacoeconomics: Health Economics and Outcomes Research. 3rd Ed.,WoltersKluwer – Wolters/Kluwer -Lippincott Williams & Wilkins, November  2020.
  2. Rascati KL Essentials of Pharmacoeconomics. Wolters Kluwer/ Lippincott, Williams, & Wilkins. Philadelphia PA; 2013.
  3. Rascati KL.Introducao – Farmacoeconomia (Portuguese translation), Artmed, Porto Alegre, Brazil; 2009.
  4. Rascati KL.  Essentials of Pharmacoeconomics. Lippincott, Williams, & Wilkins. Philadelphia PA; 2009.
  5. Wilson J and Rascati KL. Pharmacoeconomics. Chapter 7 in Drug Information: A Guide for Pharmacists, 5th Edition, McGraw Hill, 2013.
  6. Wilson J and Rascati KL. Pharmacoeconomics.  Chapter 7 in Drug Information: A Guide for Pharmacists, 4th Edition, McGraw Hill; 2009.
  7. Barner JC, Rascati KL. Cost-Benefit Analysis. Chapter 8 inPharmacoeconomics and Outcomes: Applications for Patient Care . American College of Clinical Pharmacy (AACP). Kansas City MO; 2003.
  8. Vincze G, Rascati KL, Vincze Z. Health-Related Quality of Life. Chapter 11 in Introduction to Pharmacoeconomics (Bevezetes A Farmako-Okonomiaba). Budapest, Hungary; 2001.
EXCERPTS FROM BOOK REVIEWS
 
Essential of Pharmacoeconomics is a high-quality, intellectual contribution to the pedagogy of pharmacoeconomics in pharmacy.As a pharmacy educator, after reading the book, I deeply appreciate the time and effort Dr. Rascati spent on both teaching and research in pharmacoeconomics. No doubt it was her experience from those endeavors that resulted in this book. I highly recommend the book to be used as a textbook in pharmacoeconomics courses at US pharmacy schools.
Reviwer = Y. Liu – American Journal of Pharmaceutical Education 2009;73(5) Article94.
 

Essentials of Pharmacoeconomics is a valuable resource for US pharmacy students wishing to understand the basic principles of pharmacoeconomics in order to be able to use such data in their future decision making. The book is clearly written, contains many practical exercises and provides plenty of pertinent references for those wishing to study further.
Reviewer = C. Carswell – Pharmacoeconomics 2008; 26 (12): 1065.

Students keep academic books adamantly believing that they will use them after class has ended. Unfortunately, these shelf weights see little use in a search-and-click web world. Rascati’s book is, however, an exception. Any student keeping Rascati ’ s book after class’s end would still be using it. Essentials of Pharmacoeconomics is a timely book providing beginning students an excellent introduction to pharmacoeconomics. The book earns high marks for its emphasis on research analysis, brief but inclusive explanations, and for doing in 200 pages what many books eight times the length attempt. Beginners need not run a CBA of this book. It may be profitably kept on shelves in an increasing valuing world
Reviewer = H. King Journal of Commercial Biotechnology (2009) 15, 92 – 94.
 
Book cover for Essentials of Pharmacoeconomics, third edition
 

Invited Presentations

Keynote – ACCP Health Outcomes PRN. Use of Real-World Data (RWD) October 27, 2020 – Zoom meeting.

Interpreting Cost-Effectiveness Results – Pharmacoeconomic Modeling Course Austin Texas, January 2020.

Real-World Evidence – Pfizer Headquarters, Connecticut, July 2019

Assessing Economic Outcomes of Clinical Interventions. Center for Health Promotion & Disease Prevention Research Seminar, UT School of Nursing, Austin TX, November 2018.

Using Claims Databases to Answer Research Questions: The Good, The Bad, and the Ugly. The University of Illinois Chicago College of Pharmacy Seminar. Chicago IL, September 2018.

Introduction to Pharmacoeconomics – Two-day Course – The University of Puerto Rico College of Pharmacy. September 2018.

Introduction to Pharmacoeconomics Short Course ISPOR 6th Latin America Conference, Sao Paulo Brazil September 15, 2017.

Cost-effectiveness of Diabetes Interventions – What Works? Texas Diabetes Council's Health Care Professional Committee, Austin Texas, July 27, 2017

Overview of Pharmacoeconomics, Takeda, Cambridge MA, May 25, 2017.

Transforming Pediatric Healthcare Delivery: Analysis of Texas Medicaid Claims Data to Support an Ongoing Randomized Controlled Trial. Transforming Healthcare through Research Collaboration Symposium, Austin TX, April 26, 2017.

Cost-effectiveness – The Fourth Hurdle: When will the US Take the Leap? – West Virginia University Rho Chi Bergy Lecture – Morgantown, WV – April 2016

Pharmacoeconomic and Outcomes Research – University of Texas Medical Branch – Department of Preventive Medicine and Community Health, Galveston TX, May 2014.

Rascati KL. How to Add Economic Outcomes to Clinical Trials. American College of Clinical Pharmacy (ACCP) Scholarship Certificate Program. ACCP Annual Meeting, Austin, TX October 2010.

Rascati KL. Economic and Outcome Studies in Psychiatry. Topic for CPNP 2010 BCCP Examination Review and Recertification Course. December 2009, Las Vegas, NV.

Rascati KL. Curso de Introdução àFarmacoeconomia (Course of Introduction to Pharmacoeconomics), 8 hours of lecture at the Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, September 2009.

Rascati KL, Retrospective Database Analysis: The Good, the Bad, and the Ugly. USC-ISPOR Western Pharmacoeconomics Conference. Pasadena CA, March 2009.

Rascati KL. International Society for Pharmacoeconomics and Outcomes Research Student Teleconference. What is the Value of a QALY? January 2009.

Rascati KL Short Course: Pharmacoeconomics for Decision-Makers. IXth World Clinical Pharmacology and Therapeutics (CPT) Conference, Quebec City, Canada, July 2008.

Rascati KL, Nickman N, and Gardner S. Women Faculty SIG: Women in Academic Leadership: A journey of preparation, negotiation and balance. American Association of Colleges of Pharmacy Annual Meeting. Chicago, IL, July 2008

Rascati KL, Wilson J, Hatzema A, Sketris I, and Marra, C. Pharmacoepidemiology and Pharmacoeconomics in the Curriculum. American Association of Colleges of Pharmacy Annual Meeting. Chicago, IL, July 2008

Rascati KL. Pharmacoeconomics in Mental Health. College of Psychiatric & Neurologic Pharmacists (CPNP) Annual Meeting, Scottsdale AZ, April 2008.

Rascati KL, Retrospective Database Analysis: The Good, the Bad, and the Ugly. University of Southern California Graduate Seminar. January 2007.

Rascati KL. Texas Medicaid: Patient Compliance with Atypical Anti-psychotics. The Second Annual Medicaid Summit. Park City Utah October 2005.


Research Presentations

Research Presentations (from more than 200)

Ghosh S, Richards K, Rascati K, Lawson K. Prescription Opioid Use in Women during Pregnancy - A Retrospective Analysis Using Texas Medicaid Prescription Claims Data. ISPOR Annual Montreal, Canada, May 2021 (Virtual).

Zhang S, Zhang H, Rascati K. Assessment of Adherence and Healthcare Utilization for Patients with Hepatic Encephalopathy. Academy of Managed Care Pharmacy Annual Meeting, April 2021. (Virtual) Platinum Award (1 of 4 total abstracts for virtual presentation).

Ibiloye E Barner J, Lawson K, Rascati K, Evoy K, Peckham A. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients, Academy of Managed Care Pharmacy Annual Meeting, April 2021. (Virtual) Platinum Award (1 of 4 total abstracts for virtual presentation).

Ibrahim K, King C, Orji C, Rascati K. Opioid Abuse Deterrent Formulations: A Literature Review of Economic Outcomes. Academy of Managed Care Pharmacy Annual Meeting, April 2021 (Virtual)

Ibrahim k, Lawson K, Barner J, Rascati K, Richards K.  Opioid Analgesic Use among Texas Medicaid Enrollees: Trends in Potentially Inappropriate Prescribing Practices from 2013 to 2016. AMCP Nexus, October 2020 (Virtual).

Toliver J, Rascati K. Comparison of Claims-Based Multiple Sclerosis Disease Severity Measures in The Medicare Population. ISPOR Annual Orlando FL (Virtual) May 2020.

Shukla N, Barner JC, Lawson K, Rascati K. Prescription Medication Utilization for The Management of Sickle Cell Disease by Age Group. ISPOR Annual Orlando FL (Virtual) May 2020.

Liang Y, Rascati K. Health Care Cost and Utilization Among Children with Immune Thrombocytopenia Enrolled In Texas Medicaid. ISPOR Annual Orlando FL (Virtual) May 2020.

Liu YS, Liang Y, Shao Q, Rascati K. A Review of Policies Regarding Patient-Reported Outcomes (PRO from The Food And Drug Administration (FDA) And European Medicines Agency (EMA). ISPOR Annual Orlando FL (Virtual) May 2020.

Shao Q, Rascati K, Lawson K, Wilson.  Opioid Use Among Migraine Patients at The Emergency Departments and Subsequent Migraine-Related Emergency Department Visits. ISPOR Annual Orlando FL (Virtual) May 2020.260. Ibrahim K, Lawson K, Barner JC, Rascati K, Richards K. Co-prescribing Of Opioids and Benzodiazepines in Texas Medicaid Enrollees. ISPOR Annual Orlando FL (Virtual) May 2020.

Zhang S, Rascati K, Barner JC, Richards K. Evaluation Of Progesterone (17-Alpha Hydroxyprogesterone Caproate (17-OHPA)) Utilization, Adherence, And Outcomes in Women with A High-Risk Pregnancy. ISPOR Annual Orlando FL (Virtual) May 2020.

Zhang S, Ma AX, Li H, Rascati K. Cost-Effectiveness Analysis of Regorafenib Used in Chinese Patients with Metastatic Colorectal Cancer. ISPOR Annual Orlando FL (Virtual) May 2020.

Shao Q, Liang Y, Liu YS, Rascati K. A Review of Patient-Reported Outcomes Labeling for Oncology Products Approved by FDA and EMA from 2017 To 2018. ISPOR Annual Orlando FL (Virtual) May 2020.

Zhang H, Barner JC, Moczygemba L, Rascati K. Measuring Insulin Adherence Using Adjusted Medication Possession Ratio- An Examination of The Methodology. ISPOR Annual Orlando FL (Virtual) May 2020.

Shao Q., Rascati K., Lawson K., Wilson J. Patterns and Predictors of Opioid Use among Migraine Patients at Emergency Departments. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. Silver Medal winner (Virtual)

Liang Y., Rascati K. Health Care Costs and Utilization among Adult Patients with Immune Thrombocytopenia (ITP) Enrolled in Texas Medicaid. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. Silver Medal Winner (Virtual)

Burkhart A., Toliver J., Rascati K. Adherence to Disease-Modifying Therapies for Multiple Sclerosis in the Medicare Population. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. (Virtual)

Possidente C, Johnsrud M, McClain W, Colavecchia A, Hartman T, MacLean E, Richards K, Rascati K, Lawson K, Barner JC. Development and Assessment of a Real World Evidence (RWE) Training Program for Pharmaceutical Field Medical Professionals. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. Platinum Medal  (Virtual)

Zhang S., Rascati K., Barner J., Richards K. Progesterone (17-alpha Hydroxyprogesterone Caproate) Utilization and Adherence in Women with a High-Risk Pregnancy: A Study of Two Databases. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. (Virtual)

Shukla N., Barner J., Rascati K., Lawson K.  Age-Related Healthcare Service Utilization in Sickle Cell Disease Management. Academy of Managed Care Pharmacy Annual Meeting, Houston Tx, April 2020. (Virtual)

Zhang H, Barner JC, Moczygemba LR, Rascati KL. Comparison of methods to assess basal insulin adherence among Texas Medicaid enrollees with type 2 diabetes. American Pharmacists Association (APhA) Annual Meeting & Exposition, National Harbor, MD, March 2020

Coleman A, Vohra Y, Rascati KL. Antibiotic Utilization and Efficacy Associated with Treating Pediatric Urinary Tract Infections in Texas Medicaid Patients, 2019 ASHP Midyear Las Vegas, NV, December 2019.

LaVallee C, Gums T, Rascati KL. Antihypertensive Agent Utilization Among Patients with Uncontrolled Hypertension In The United States. ISPOR European Meeting, Copenhagen, Denmark, November 2019.

Coleman, A, and Rascati KL. Antibiotic Utilization Associated with Treating Pediatric Urinary Tract Infections in Texas Medicaid. AMCP Nexus, Bar Harbor MD, October 2019.

LaVallee C, Rascati KL, Gums T. Antihypertensive Agent Utilization Among Patients with Uncontrolled Hypertension In The United States. AMCP Nexus, Bar Harbor MD, October 2019.

Karen Rascati, Carolyn Brown, W. Ray Kim, David Halajko, Guy W. Neff. Reliability and Validity Assessment of the Chronic Liver Disease Questionnaire NAFLD-NASH in Patients with Non-Alcoholic Fatty Liver Disease In The Community-Based Setting. Digestive Disease Week - San Diego CA May 2019

Y. Liang, K. Rascati. Prevalence of Primary Immune Thrombocytopenia Among Texas Medicaid Beneficiaries: Analyses of an Administrative Claims Database ISPOR May 2019 New Orleans, LA

H.A. Kang, J.C. Barner, K. Rascati, K.A. Lawson, R. Mignacca. Association Between Hydroxyurea Medication Adherence and All-Cause and Disease-Related Healthcare Expenditures Among Texas Medicaid Enrollees with Sickle Cell Disease ISPOR May 2019 New Orleans, LA

E. Pineda, J. Goble, K. Zolfaghari, P.J. Godley, L. Copeland, D.N. Hartzel, K. Rascati, L. Webster. Multi-Center Study on the Impact of Cytochrome P450 3a4 and P-Glycoprotein Interacting Medications on Bleeding and Thromboembolism Risk in Nonvalvular Atrial Fibrillation Patients Managed on Rivaroxaban Therapy ISPOR May 2019 New Orleans, LA

E. Pineda, I.C. Liao, P.J. Godley, J. Michel, K. Rascati.. Demographic and Clinical Profiles of Patients with Type 2 Diabetes Newly Initiating Sodium-Glucose Cotransporter-2 Inhibitors Compared to Glucagon-Like Peptide-1 Receptor Agonists ISPOR May 2019 New Orleans, LA

S. Zhang, K. Rascati.  Evaluation of Progesterone (17-Alpha Hydroxyprogesterone Caproate) Utilization and Adherence in Women With A High-Risk Pregnancy ISPOR May 2019 New Orleans, LA

Q. Shao, K. Rascati, S. Shah. Opioid Use Among Migraine Patients Presenting to the Emergency Department (ED) of a Large Tertiary Care Integrated Delivery Network In Texas ISPOR May 2019 New Orleans, LA

C. Orji, S. Nduaguba, N. Shukla, Y. Vohra, K. Rascati. Health-Related Quality of Life Inequalities by Gender Identity And Sexual Orientation and Role Of Depression As An Explanatory Variable ISPOR May 2019 New Orleans, LA

J. Toliver, K. Rascati Replication of a US Claims Based Algorithm To Identify Multiple Sclerosis Disease Severity Based on Healthcare Costs ISPOR May 2019 New Orleans, LA

Conner TM, Cook FM, Cho Y, Fernandez V, Rascati KL. An Analysis of Outpatient Healthcare Utilization and Costs in Children with Severe Mucopolysaccharidosis Type I in The United States. May 2018, ISPOR 2018, Baltimore, MD.

Nina Kim, Paul Godley, Karen Rascati, Jeffrey Michel “Impact of Obesity on Real-World Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation on Direct Oral Anticoagulant Therapy: A Retrospective Cohort Study”  AMCP - San Diego, California, March 25-28, 2019.

Gladys Brown, Shiyu Zhang, Karen Rascati “Evaluation of Progesterone (17 α-Hydroxyprogesterone Caproate) Utilization and Adherence in Women with a High-risk Pregnancy Covered by Texas Medicaid” AMCP - San Diego, California, March 25-28, 2019.

Qiujun Shao, Sanket Shah, Karen Rascati. “Opioid Use at The Emergency Department (ED) Of A Large Tertiary Care Integrated Delivery Network In Texas”  AMCP - San Diego, California, March 25-28, 2019.

Shiyu Zhang, Gladys Brown, Karen Rascati.  Evaluation of Progesterone Utilization and Adherence in Women with a High-risk Pregnancy Covered by Texas Medicaid APhA – March 2019, Seattle WA

Kanu C, Brown C, Rascati K, Moczygemba L, Mackert M Wilfong L. The Relationship between Health Literacy, Patient Activation, and Health Outcomes in Breast Cancer Patients APhA – March 2019, Seattle WA                         

Kang HA, Barner JC, Rascati KL, Lawson KA, Mignacca R.  Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees With Sickle Cell Disease May 2018, ISPOR 2018, Baltimore, MD.    

Shah S, Rascati KL, Brown CM, Khan F, Thach A, Desai P.  Opioid Use Among Patients Presenting with Migraine in the Emergency Department. May 2018, ISPOR 2018, Baltimore, MD.

Ghosh S, Rascati KL, Shah A, Peeples P.  Predictors of Annual Salary For Health Economics, Outcomes Research, and Market Access Professionals. May 2018, ISPOR 2018, Baltimore, MD.                         

Yi EJ, Zolfaghari K, Chen L, Godley PJ, Michel J, Rascati KL.  The Impact of A Value-Based Insurance Design for Chronic Preventive Medications on Adherence and Persistence in An Integrated Delivery System. May 2018, ISPOR 2018, Baltimore, MD.

Berhane R. Wakefield T, Marshall L, Alexander MA, Jesser C Rascati K Rocenbloom A, Koch K, Shen M.  Population characteristics and correlation to total Medicaid costs in a cohort of children with medical complexity (CMC). Pediatric Academic Society (PAS) Meeting Toronto Canada, April-May, 2018.

Berhane R, Alexander MA, Jesser C, Wakefield T Marshall L Rascati K, Koch K, Shen M. Effect of an integrated, comprehensive clinic on health costs for Medicaid insured children with medical complexity in a randomized control trial.  Pediatric Academic Society (PAS) Meeting Toronto Canada, April-May, 2018.

Marshall L, Rascati K, Jesser C, Alexander MA, Rosenbloom A, Shen M, Berhane R. A Retrospective Analysis of Prescription Expenditures Among Medicaid Eligible Children With Medical Complexities Enrolled In A Randomized Controlled Trial.  Pediatric Academic Society (PAS) Meeting Toronto Canada, April-May, 2018.

Shrestha S. Temple H, Rascati K.  Interacting with Older Adults: Improving Comfort Level and Empathy via Simulation. UT COP Research Day, April 2018.

Liang Y, Toliver J, Rascati K. An Evaluation of Database Studies Published in the Journal of Managed Care & Specialty Pharmacy: Reproducibility Using ISPE-ISPOR Reporting Criteria. Academy of Managed Care Pharmacy (AMCP) Annual Meeting. Boston MA, April 2018.

Marshall LZ, Rascati KL. Costs Associated with A Pediatrician-Led Care Model. Serving Children with Medical Complexities.  ISPOR European Meeting, Glasgow, Scotland, November 2017.

Yi E, Godley P, Rascati, K, Goble, J. Identifying Primary Non-adherence to Prescribed Antibiotics Using Point-of Sale Data. AMCP Nexus, Grapevine Texas, October 2017.

Marshall LZ, Rascati KL. Prescription Drug Use and Cost Associated with a Pediatrician-Led Care Model Serving Children With Special Healthcare Needs (CSHN) with Complex Chronic Conditions (CCC).  ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Heo JH, Park C, Rascati KL. Indirect Comparisons of Safety of Targeted Therapies for Metastatic Renal Cell Carcinoma: A Network Meta-Analysis. ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Marshall LZ, Rascati KL. Prescription Drug Use and Cost Associated with a Pediatrician-Led Care Model Serving Children With Special Healthcare Needs (CSHN) with Complex Chronic Conditions (CCC). ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Heo JH, Park C, Rascati KL. Indirect Comparisons of Safety of Targeted Therapies for Metastatic Renal Cell Carcinoma: A Network Meta-Analysis. ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Heo JH, Vohra Y, Ghosh S, Rascati KL. The Effect of Short-Acting Β2-Agonists on Arrhythmia for Pediatric Patients with Bronchopulmonary Dysplasia and Congenital Heart Disease Using Texas Medicaid Database. ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Park C, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. Comorbidity Measures to Predict Overall Survival Time Among Elderly Gynecologic Cancer Survivors in the US: An Analysis Of SEER-Medicare Data. ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Park C, Lawson KA, Barner JC, Powers DA, Rascati KL, Wilson JP. Comorbidity Measures to Predict Healthcare Costs Among Elderly Gynecologic Cancer Survivors in the US: An Analysis of SEER-Medicare Data. ISPOR 22nd Annual International Meeting Boston, MA, USA May, 2017.

Best Graduate Student Poster: Shah S, Rascati KL.  Cost Comparison Analysis of Recurrent Clostridium difficile treated with Fecal Microbiota Transplants vs. Antimicrobial Therapy. Academy of Managed Care Pharmacy Annual Meeting, Denver Co. March 2017.

Heo JH, Rascati KL, Moffett B, Lopez KN. “Association of Fractures with Furosemide Therapy in Pediatric Medicaid Patients with Congenital Heart Disease” submitted for American College of Cardiology Annual Scientific Session & Expo, Washington DC, March 2017.  Chosen for special presentation with Q&A.

Popp RA, Davis M, Rascati KR. Application of an algorithm to estimate effectiveness of biologics for rheumatoid arthritis in a large insurance database. ASHP Mid-year Meeting, Las Vega NV, December 2016.

Grisham-Takac C, Lai PH, Srinivasa M, Vasquez LS , Rascati KL. Correlation Between Antidepressant Dose Optimization and Achievement of Glycemic or Blood Pressure Control. ASHP Mid-year Meeting, Las Vega NV, December 2016.

Alshehri A., Barner J., Carolyn B., Ford K., Rascati K., Atif S. “The relationship between Muslims’ perceptions of Islamophobia and perceived healthcare barriers” at the Addressing Health Disparities: The Role of Translational Research” on the Meharry Medical College, Nashville, Tennessee, November 10-11, 2016

Rascati KL, Popp R, Davis, M. Comparison of Estimated Effectiveness of Biologics for Rheumatoid Arthritis (RA) in Large Insurance Databases Using a Claims-Based Algorithm. ISPOR 19th Annual European Congress Vienna, Austria, October, 2016.

Ling YL, Rascati KL, Suehs B. Impact of Adherence to Antidepressants on Healthcare Resource Utilization and Costs Among Medicare Advantage Beneficiaries with Parkinson’s Disease and Depression. AMCP Nexus meeting, National Harbor MS, October 2016

Xiang P, Tran M, Rascati K, Stock E, Godley P, Coleman A, Bogart M, Stanford R. Predictors of Readmission Rates After COPD-Related Hospital or Emergency Department Visits. AMCP Annual Meeting, San Francisco, CA, April, 2016.

Desai P, Lawson K, Richards K, Rascati K. et al. Assessing Factors Associated With Antipsychotic Polypharmacy in The Texas Medicaid Population. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Heo J and Rascati K. Comparison of Latanoprost, Travoprost, and Bimatoprost on Adherence, Persistence, And Pattern of initial Therapy in Glaucoma and Ocular Hypertension: An Administrative Claims Database Analysis. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Gupte-Singh K, Barner J, Wilson J, Hovinga C, Richards K, Rascati K. Health Care Utilization and Costs Associated With Potential Refractory Epilepsy in Texas Medicaid. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Tran M, Xiang P, Rascati K Stock Godley P et al. Hedis Quality Measure Performance And Other Factors Predictive of Health Care Costs Following COPD-Related Admission. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Scalo J, Rascati KPredictors and Prevalence of Sleep Disturbance and Hypnotic Use in Persons with Cancer. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Xiang P, Tran M, Rascati K et al. Six-Month Cost Assessment after COPD-Related Hospital or Emergency Department Visits. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016

Gupta-Singh K, Wilson J, Barner J Hovinga C, Rascati K, Richards K. Treatment Patterns of Antiepileptic Drugs in Patients With Potential Refractory Epilepsy in The Texas Medicaid Program. ISPOR 21st Annual International Meeting, Washington DC, USA, May, 2016.

Rascati, KL, Worley K, Meah Y, Everhart D. Costs for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) inhibitors in US Medicare and Commercial insurance Plans. ISPOR European Congress, November 2015, Milan Italy.

Rascati, KL, Worley K, Meah Y, Everhart D. Characteristics of and Medication Adherence for Diabetic Patients Receiving Dipeptidyl Peptidase-4 (DPP-4) inhibitors in US Medicare and Commercial insurance Plans. AMCP Nexus 2015, Orlando FL, October 2015.

Tran M, Rascati KL, Stock EM. Godley PJ Coleman A, Bogart MR, Stanford RH. Predictors of Pharmacotherapy Management of COPD Exacerbations Post-hospitalization/ED Visit as Defined by HEDIS. AMCP Nexus 2015, Orlando FL, October 2015.

Shah S, Rascato KL, Scalo J. Risk of injury with Sedative Hypnotic Use in an Over-65 Population . ISPE’s 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE), Boston MA, August 2015.

Ogunsanya ME, Thach AV, Bamgbade B, Sudhapalli P, Rascati K. Stress and Health-Related Quality of Life among Graduate Students: A Cross-Sectional Study. American Association of Colleges of Pharmacy Conference, National Harbor, Maryland (Washington, D.C. Area). July 2015.

Tran M, Godley P, Stock EM, Rascati KL, Tabor PA. Long-Term Impact of a Pharmacist-Led Diabetes Medication Management Program On Glycemic Control, May 2015, ISPOR 20th Annual International Meeting, Philadelphia, PA,

Al-Efan QM1, Al-Emam S, Mukattash TL, Mhaidat NM, Al-Abbadi I, Rascati K. Pharmacoeconomics Education in WHO Eastern Mediterranean Region, May 2015, ISPOR 20th Annual International Meeting, Philadelphia, PA.

Gupte KP, Rascati KL, Wilson JP. Treatment Patterns of Monotherapy versus Combination Antiepileptic Drug Therapy in Patients with Epilepsy. May 2015, ISPOR 20th Annual International Meeting, Philadelphia, PA.

Rascati KL and Richards K. Level of Testing for Potential Medicationn-related Co-morbidities for Patients Taking Antipsychotics. International Society for Pharmacoeconomics and Outcomes Research European Meeting, Amsterdam, The Netherlands, November 2014.

Makhinova T, Barner JC, Richards KM, Rascati KL Long-term Controller Medication Adherence and Use of SABAs and Oral Corticosteroids among Texas Medicaid Patients with Asthma. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Kim YA, Nguyen M, Richards KM, Wilson JP, Rascati KL. Poor Adherence to HCV Medication in a Medicaid Population. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Adeyemi AO, Rascati KL, Lawson K, Barner JC, Novak S. Evaluation of the effect of BMI status on healthcare costs of type 2 diabetes patients. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Adeyemi AO, Rascati KL, Lawson K, Barner JC, Novak S. Evaluation of the effect of BMI status on health-related quality of life of type 2 diabetes patients. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Heo JH, Rascati KL, Lee EK. Estimation of Change in Prescription Drug Expenditures on the Reference Pricing System in South Korea International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Kim G, Barner JC, Rascati K, Richards K. Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Kim-Romo D, Rascati KL. 10-Year Medication Utilization Trends for Stimulant, Antipsychotic, and Antidepressant Medications in Texas Medicaid Children Aged 3 Years Old or Younger. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Ling YL, Rascati K. Outcomes and expenditures of clostridium difficile infection in pediatric solid organ transplant recipients in the United States. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Oladapo A, Barner JC, Richards K, Rascati KL, Lawson KA, Novak S, Harrison DJ. Healthcare Utilization, Costs, and Medication Use Patterms of TNF Inhibitors among Texas Medicaid Patients Diagnosed with Rheumatoid Arthritis. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Ogunsanya ME, Bamgbade BA, Thach AV, Sudhapalli P, Rascati KL. Stress (Perceived and Acculturative) and Health Related Quality of Life among Graduate Students in the ISPOR Student Network: A PILOT STUDY. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Thach A, Jiang S, Rascati K. A systematic review of health-related quality of life assessment for children and adolescents with chronic kidney disease. International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting, Montreal, QC, Canada, May 31 – June 4, 2014.

Kim-Romo D, Rascati KL. Stimulant Medication Utilization in Foster and Non-foster Medicaid Children 3 Years of Age or Younger American Pharmacists Association (APhA) Annual Meeting & Exposition 2014, Orlando, FL, Mar 2014.

Park H, Rascati KL, Lawson KA, Barner JC, Richards KE, Malone DC. “The Impact of Medicare Part D Coverage on Health Outcomes in End-Stage Renal Disease (ESRD) Patients” at the American Pharmacists Association (APhA) Annual Meeting & Exposition 2014, Orlando, FL, Mar 2014. *Awarded 2014 APhA-APRS Postgraduate Best Paper Award in the Economic, Social & Administrative Sciences.

Kim-Romo D, Rascati KL. 10-Year Medication Utilization Trends for Second-generation Antipsychotics in Texas Medicaid Children 3 Years of Age or Younger. Academy of Managed Care Pharmacy (AMCP) 26th Annual Meeting, Tampa, FL, April, 2014

Cheng LI, Rascati KL. Impact of Medicare Part D on Prescription Use, Health Care Expenditures, and Health Services Utilization: National Estimates for Medicare Beneficiaries, 2002 to 2009. ISPOR 16th Annual European Congress, Dublin, Ireland, November 2013.

Nwokeji ED, Rascati KL, Nemeth WC, Jordan K, Novak S, Adeyemi AO. Examining the Effects of a Functional Restoration and Pain Management Program Among Chronic Pain Patients in the Texas Workers Compensation System: Pilot Study‐ Part 1. ISPOR 16th Annual European Congress, Dublin, Ireland, November 2013.

Park H, Rascati KL, Lawson KA, Barner J, Richards K, Malone DC, Impact of Medicare Part D Coverage on Health Outcomes In End-Stage Renal Disease. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013

Jiang S, Ma X, Desai P, Rascati KL. A Systematic Review on the Quality of Pharmacoeconomics Studies In China. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013

Desai P, Lawson K, Rascati KL, Richards EK. Indirect Costs of Schizophrenia for Community-Dwelling Texas Residents. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Rascati KL, Lawson K, Richards K, Desai P, Miller A. Burden of Schizophrenia in Texas. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Griggs SK, Brown C, Lawson KA, Rascati KL, Wilson JP. Examination of University Students’ Intention to Utilize Emergency Contraception Using the Theory Of Planned Behavior. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Shcherbakova N, Rascati KL, Brown CM, Lawson K, Richards EK, Novak S, Yoder L. Acute Care Utilization in Patients with Epilepsy on Antiepileptic Monotherapy. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Scalo JF, Desai P, Rascati KL. Quality Of Life Scores Associated With Insomnia and Use of Hypnotic Medications. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Chandwani H, Strassels S, Rascati KL, Lawson KA, Wilson JP. Predictors of Inpatient Admission Following Opioid Analgesic Abuse-Related Emergency Department Visits in the United States. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Adeyemi A, Rascati KL, Cheng LI, Prasla K. Assessment of the Incidence of Flares for Gouty Arthritis Patients within the Scott & White Health Care System. ISPOR 18th Annual International Meeting, New Orleans LA, May 2013.

Park H, Rascati KL, Keith MS. Impact Model of Medicare Bundled End-stage Renal Disease Prospective Payment System: A Dialysis Organization Perspective, accepted for American Society of Nephrology (ASN) meeting, San Diego CA, October, 2012

Makhinova T, Makhinova EN, Rascati KL. Pharmacoeconomic Education for Pharmacy Students in the Russian Federation. Accepted for ISPOR 15th Annual European Congress, Berlin, Germany, November 2012.

Chandwani HS, Strassels SA, Rascati KL, Lawson KA, Wilson JP. Emergency Department Visits and Inpatient Admissions for Opioid Abuse-Related Events: National Estimates for the United States (2006–2008). International Society for Pharmacoepidemiology, Barcelona, Spain August, 2012.

Makhinova T, Rascati KL. An Update (2011) on Pharmacoeconomic

Education in US Schools and Colleges of Pharmacy. American Association of Colleges of Pharmacy (AACP) Annual Meeting, Kissimmee FL, June 2012

Park H, Park C, Kim Y, Rascati KL. A Meta_Ananlysis of Efficacy and Safty of DPP4 Inhibitors in Type 2 Diabetes. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Adeyemi A, Rascati KL, Strassels S, Lawson K. Adherence to Oral Antidiabetic Medications in the Pediatric Populations with Type 2 Diabetes. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Cheng LI, Rascati KL. Effect of Medicare Part D on Drug Utilization, Drug Expenditures, and Health Care Spending in Patients with Chronic Pulmonary Obstructive Disease. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Desai P, Lawson K, Rascati KL, Barner JC. Identifying Characteristics of Patients With High Schizophrenia-Related Costs. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Chandwani H, Strassels S, Rascati KL, Lawson K, Wilson JP National Estimates And Potential Predictors of Emergency Department (ED) and Inpatient Care Costs For Events Related To Abuse or Misuse of Opioid Analgesics. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Makhinova T, Rascati KL. Pharmacoeconomic Education in Schools and Colleges of Pharmacy in 2011 in the United States. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Gavaza P, Brown CM, Rascati KL, Lawson K, Wilson JP, Steinhardt MA. Using The Theory of Planned Behavior To Predict Texas Pharmacists’ Intention To Report Serious Adverse Drug Events To The FDA. ISPOR 17th Annual International Meeting, Washington, D.C. June 2012.

Rascati KL, Richards K, Nwokeji E. Once−Monthly Depot Medication Use by Children with Central Precocious Puberty (CPP) in the Texas Medicaid Population. Pediatric Academic Societies (PAS). Boston MA, April 2012

Cheng L, Rascati KL. Predicting healthcare expenditures and utilization in patients with dyslipidemia using the updated Charlson comorbidity index (CCI) and prior expenditures. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011

Cheng L, Rascati KL. Validation of the updated Charlson comorbidity index (CCI) for use in patients with diabetes or asthma: a comparison study. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011

Cheng L, Rascati KL. Validating an alternative weighting algorithm of the Charlson comorbidity index (CCI) for risk adjustment in previously hospitalized patients. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011.

Rascati ME, Park H, Rascati KL. Direct Costs Of Head And Neck Cancer in the US: An Analysis Using 2008 Medical Expenditure Panel Survey (MEPS) Data. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011.

Park H, Rascati KL direct costs of pneumonia in the united states: an analysis of 2008 medical expenditure panel survey (MEPS) data. ISPOR 14th Annual European Congress, Madrid, Spain, November 2011.

Rascati KL, Prasla K, Park H, McBayne T. “Evaluation of healthcare costs for patients with gout by serum uric acid” at the American College of Rheumatology 75th Annual Scientific Meeting, Chicago, IL. Nov 2011.

Bird AM, Smith TL, Mican LM, Rascati KL. Impact of the CATIE Tiral on Antipsychotic Prescribing Patterns at a State Psychiatric Facility. Annual College of Psychiatric and Neurologic Pharmacists (CPNP) Meeting, Phoenix, AZ, May 2011.

Cheng L, Rascati KL, Trice SK, Lawson KA, Barner JC. Validation of the Updated Charlson Comorbidity Index (CCI) to Predict Healthcare Utilization for Diabetic Patients Using Administrative Data.  International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011. *Awarded Best Student Podium Award

Kim D, Park H, Rascati KL , Measures of medication adherence in orals vs. long-acting risperidone in Texas Medicaid patients with schizophrenia. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011. * Awarded Best Poster Award

Desai P, Chandwani H, Rascati K. Assessing the Quality of Pharmacoeconomics Studies in India: A Systematic Review. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Park H, Kim DN, Rascati KL. Comparisons of Mental Health-Related Medical Care Utilization and Costs Following the Initiation of Oral vs. Long-Acting Injectable Risperidone in Patients with Schizophrenia. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Desai P, Lawson K, Barner JC, Rascati KL. Estimation of Direct Costs of Treating Schizophrenia for Community Dwelling Residents in the United States. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Oladapo AO, Barner JC, Rascati KL, Strassels S. Examining Adherence with Medications used in Treating Diabetic Peripheral Neuropathic Pain and Their Association with Oral anti-diabetic Medication Adherence. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Gavaza P, Rascati KL, Oladapo AO, Khoza S. The State of Health Economics Evaluation in South Africa: A Systematic Review.International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Khoza S, Barner JC, Lawson K, Rascati KL, Wilson JP, Bohman TM. Use of Antidepressants and the Risk of Diabetes Mellitus: A Retrospective Cohort Study. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Khoza S, Barner JC, Lawson K, Rascati KL, Wilson JP, Bohman TM. Use of Antidepressants and the Risk of Diabetes Mellitus: A Nested Case-Control Study. International Society of Outcomes and Pharmacoeconomics Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, May 2011.

Rascati K, Richards K, Stafkey-Mailey D, Ott C, Goddard A, Alvir J,Sanders K. Adherence, Persistence, and Medical Costs Associated with the Use of Clinically Effective Doses of Antipsychotic Medications in Patients with Bipolar Disorder. Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011

Rascati K, Prasla K, Park H, McBayne T, Comparison of Health Care Costs for Gout Patients by Uric Acid Level Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN. April 2011.

Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascati K, Serxner S, Evaluation of a Value-Based Insurance Design in a Large Retail Employer Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011.

Cheng L, Rascati K, Trice SK, Barner JC, Lawson KA, Performance of Different Comorbidity Measures to Predict Health Care Expenditures, Hospitalizations, and Emergency Department Visits for Patients with Diabetes Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Minneapolis, MN, April 2011.

Park H, Kim YA, Rascati KL, Efficacy and safety of dipeptidyl-peptidase 4 [DPP4] inhibitors in type 2 diabetes: Meta-analysis. American Pharmacists Association (AphA) Annual Meeting & Exposition 2011,Seattle, WA, March 2011. * Awarded 2011 APhA-APRS Postgraduate Best Paper Award-ESAS Poster.

Contact Information
Phone:
Campus location:
PHR 3.209A

US Mail Address:
The University of Texas at Austin
Health Outcomes
2409 University Avenue, STOP A1930
Austin, TX 78712-1120

FEDEX Address:
2409 University Avenue
Health Outcomes
PHR 3.209A
The University of Texas at Austin
Austin, TX 78712